Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico
Clinical trial NCT03630705 · COMPLETED
Trial details
- NCT number
- NCT03630705
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2022-02-18
- Enrollment
- 525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.